Crystallography, Molecular Modeling, and COX-2 Inhibition Studies on Indolizine Derivatives
The cyclooxygenase-2 (COX-2) enzyme is an important target for drug discovery and development of novel anti-inflammatory agents. Selective COX-2 inhibitors have the advantage of reduced side-effects, which result from COX-1 inhibition that is usually observed with nonselective COX inhibitors. In thi...
Main Authors: | , , , , , , , , , , , , , , , , , , , , , |
---|---|
Format: | Article |
Language: | English |
Published: |
MDPI AG
2021-06-01
|
Series: | Molecules |
Subjects: | |
Online Access: | https://www.mdpi.com/1420-3049/26/12/3550 |
id |
doaj-a93033df97874456b6deecfd06366840 |
---|---|
record_format |
Article |
collection |
DOAJ |
language |
English |
format |
Article |
sources |
DOAJ |
author |
Katharigatta N. Venugopala Sandeep Chandrashekharappa Christophe Tratrat Pran Kishore Deb Rahul D. Nagdeve Susanta K. Nayak Mohamed A. Morsy Pobitra Borah Fawzi M. Mahomoodally Raghu Prasad Mailavaram Mahesh Attimarad Bandar E. Aldhubiab Nagaraja Sreeharsha Anroop B. Nair Osama I. Alwassil Michelyne Haroun Viresh Mohanlall Pottathil Shinu Rashmi Venugopala Mahmoud Kandeel Belakatte P. Nandeshwarappa Yasmine F. Ibrahim |
spellingShingle |
Katharigatta N. Venugopala Sandeep Chandrashekharappa Christophe Tratrat Pran Kishore Deb Rahul D. Nagdeve Susanta K. Nayak Mohamed A. Morsy Pobitra Borah Fawzi M. Mahomoodally Raghu Prasad Mailavaram Mahesh Attimarad Bandar E. Aldhubiab Nagaraja Sreeharsha Anroop B. Nair Osama I. Alwassil Michelyne Haroun Viresh Mohanlall Pottathil Shinu Rashmi Venugopala Mahmoud Kandeel Belakatte P. Nandeshwarappa Yasmine F. Ibrahim Crystallography, Molecular Modeling, and COX-2 Inhibition Studies on Indolizine Derivatives Molecules indolizine derivatives molecular modeling COX-2 inhibition crystal structure Hirshfeld surface analysis energy framework |
author_facet |
Katharigatta N. Venugopala Sandeep Chandrashekharappa Christophe Tratrat Pran Kishore Deb Rahul D. Nagdeve Susanta K. Nayak Mohamed A. Morsy Pobitra Borah Fawzi M. Mahomoodally Raghu Prasad Mailavaram Mahesh Attimarad Bandar E. Aldhubiab Nagaraja Sreeharsha Anroop B. Nair Osama I. Alwassil Michelyne Haroun Viresh Mohanlall Pottathil Shinu Rashmi Venugopala Mahmoud Kandeel Belakatte P. Nandeshwarappa Yasmine F. Ibrahim |
author_sort |
Katharigatta N. Venugopala |
title |
Crystallography, Molecular Modeling, and COX-2 Inhibition Studies on Indolizine Derivatives |
title_short |
Crystallography, Molecular Modeling, and COX-2 Inhibition Studies on Indolizine Derivatives |
title_full |
Crystallography, Molecular Modeling, and COX-2 Inhibition Studies on Indolizine Derivatives |
title_fullStr |
Crystallography, Molecular Modeling, and COX-2 Inhibition Studies on Indolizine Derivatives |
title_full_unstemmed |
Crystallography, Molecular Modeling, and COX-2 Inhibition Studies on Indolizine Derivatives |
title_sort |
crystallography, molecular modeling, and cox-2 inhibition studies on indolizine derivatives |
publisher |
MDPI AG |
series |
Molecules |
issn |
1420-3049 |
publishDate |
2021-06-01 |
description |
The cyclooxygenase-2 (COX-2) enzyme is an important target for drug discovery and development of novel anti-inflammatory agents. Selective COX-2 inhibitors have the advantage of reduced side-effects, which result from COX-1 inhibition that is usually observed with nonselective COX inhibitors. In this study, the design and synthesis of a new series of 7-methoxy indolizines as bioisostere indomethacin analogues (<b>5a</b>–<b>e</b>) were carried out and evaluated for COX-2 enzyme inhibition. All the compounds showed activity in micromolar ranges, and the compound diethyl 3-(4-cyanobenzoyl)-7-methoxyindolizine-1,2-dicarboxylate (<b>5a</b>) emerged as a promising COX-2 inhibitor with an IC<sub>50</sub> of 5.84 µM, as compared to indomethacin (IC<sub>50</sub> = 6.84 µM). The molecular modeling study of indolizines indicated that hydrophobic interactions were the major contribution to COX-2 inhibition. The title compound diethyl 3-(4-bromobenzoyl)-7-methoxyindolizine-1,2-dicarboxylate (<b>5c</b>) was subjected for single-crystal X-ray studies, Hirshfeld surface analysis, and energy framework calculations. The X-ray diffraction analysis showed that the molecule (<b>5c</b>) crystallizes in the monoclinic crystal system with space group <i>P</i> 2<sub>1</sub>/n with <i>a</i> = 12.0497(6)Å, <i>b</i> = 17.8324(10)Å, <i>c</i> = 19.6052(11)Å, <i>α</i> = 90.000°, <i>β</i> = 100.372(1)°, <i>γ</i> = 90.000°, and V = 4143.8(4)Å<sup>3</sup>. In addition, with the help of <i>Crystal Explorer</i> software program using the B3LYP/6-31G(d, p) basis set, the theoretical calculation of the interaction and graphical representation of energy value was measured in the form of the energy framework in terms of coulombic, dispersion, and total energy. |
topic |
indolizine derivatives molecular modeling COX-2 inhibition crystal structure Hirshfeld surface analysis energy framework |
url |
https://www.mdpi.com/1420-3049/26/12/3550 |
work_keys_str_mv |
AT katharigattanvenugopala crystallographymolecularmodelingandcox2inhibitionstudiesonindolizinederivatives AT sandeepchandrashekharappa crystallographymolecularmodelingandcox2inhibitionstudiesonindolizinederivatives AT christophetratrat crystallographymolecularmodelingandcox2inhibitionstudiesonindolizinederivatives AT prankishoredeb crystallographymolecularmodelingandcox2inhibitionstudiesonindolizinederivatives AT rahuldnagdeve crystallographymolecularmodelingandcox2inhibitionstudiesonindolizinederivatives AT susantaknayak crystallographymolecularmodelingandcox2inhibitionstudiesonindolizinederivatives AT mohamedamorsy crystallographymolecularmodelingandcox2inhibitionstudiesonindolizinederivatives AT pobitraborah crystallographymolecularmodelingandcox2inhibitionstudiesonindolizinederivatives AT fawzimmahomoodally crystallographymolecularmodelingandcox2inhibitionstudiesonindolizinederivatives AT raghuprasadmailavaram crystallographymolecularmodelingandcox2inhibitionstudiesonindolizinederivatives AT maheshattimarad crystallographymolecularmodelingandcox2inhibitionstudiesonindolizinederivatives AT bandarealdhubiab crystallographymolecularmodelingandcox2inhibitionstudiesonindolizinederivatives AT nagarajasreeharsha crystallographymolecularmodelingandcox2inhibitionstudiesonindolizinederivatives AT anroopbnair crystallographymolecularmodelingandcox2inhibitionstudiesonindolizinederivatives AT osamaialwassil crystallographymolecularmodelingandcox2inhibitionstudiesonindolizinederivatives AT michelyneharoun crystallographymolecularmodelingandcox2inhibitionstudiesonindolizinederivatives AT vireshmohanlall crystallographymolecularmodelingandcox2inhibitionstudiesonindolizinederivatives AT pottathilshinu crystallographymolecularmodelingandcox2inhibitionstudiesonindolizinederivatives AT rashmivenugopala crystallographymolecularmodelingandcox2inhibitionstudiesonindolizinederivatives AT mahmoudkandeel crystallographymolecularmodelingandcox2inhibitionstudiesonindolizinederivatives AT belakattepnandeshwarappa crystallographymolecularmodelingandcox2inhibitionstudiesonindolizinederivatives AT yasminefibrahim crystallographymolecularmodelingandcox2inhibitionstudiesonindolizinederivatives |
_version_ |
1721350356261142528 |
spelling |
doaj-a93033df97874456b6deecfd063668402021-06-30T23:50:52ZengMDPI AGMolecules1420-30492021-06-01263550355010.3390/molecules26123550Crystallography, Molecular Modeling, and COX-2 Inhibition Studies on Indolizine DerivativesKatharigatta N. Venugopala0Sandeep Chandrashekharappa1Christophe Tratrat2Pran Kishore Deb3Rahul D. Nagdeve4Susanta K. Nayak5Mohamed A. Morsy6Pobitra Borah7Fawzi M. Mahomoodally8Raghu Prasad Mailavaram9Mahesh Attimarad10Bandar E. Aldhubiab11Nagaraja Sreeharsha12Anroop B. Nair13Osama I. Alwassil14Michelyne Haroun15Viresh Mohanlall16Pottathil Shinu17Rashmi Venugopala18Mahmoud Kandeel19Belakatte P. Nandeshwarappa20Yasmine F. Ibrahim21Department of Pharmaceutical Sciences, College of Clinical Pharmacy, King Faisal University, Al-Ahsa 31982, Saudi ArabiaDepartment of Medicinal Chemistry, National Institute of Pharmaceutical Education and Research (NIPER-R) Raebareli, Lucknow UP 226002, IndiaDepartment of Pharmaceutical Sciences, College of Clinical Pharmacy, King Faisal University, Al-Ahsa 31982, Saudi ArabiaFaculty of Pharmacy, Philadelphia University, Amman 19392, JordanDepartment of Chemistry, Visvesvaraya National Institute of Technology, Nagpur 440010, Maharashtra, IndiaDepartment of Chemistry, Visvesvaraya National Institute of Technology, Nagpur 440010, Maharashtra, IndiaDepartment of Pharmaceutical Sciences, College of Clinical Pharmacy, King Faisal University, Al-Ahsa 31982, Saudi ArabiaPratiksha Institute of Pharmaceutical Sciences, Chandrapur Road, Panikhaiti, Guwahati 781026, Assam, IndiaDepartment of Health Sciences, Faculty of Medicine and Health Sciences, University of Mauritius, Réduit 80835, MauritiusDepartment of Pharmaceutical Chemistry, Shri Vishnu College of Pharmacy, Vishnupur, Bhimavaram 534202, IndiaDepartment of Pharmaceutical Sciences, College of Clinical Pharmacy, King Faisal University, Al-Ahsa 31982, Saudi ArabiaDepartment of Pharmaceutical Sciences, College of Clinical Pharmacy, King Faisal University, Al-Ahsa 31982, Saudi ArabiaDepartment of Pharmaceutical Sciences, College of Clinical Pharmacy, King Faisal University, Al-Ahsa 31982, Saudi ArabiaDepartment of Pharmaceutical Sciences, College of Clinical Pharmacy, King Faisal University, Al-Ahsa 31982, Saudi ArabiaDepartment of Pharmaceutical Sciences, College of Pharmacy, King Saud bin Abdulaziz University for Health Sciences, Riyadh 11481, Saudi ArabiaDepartment of Pharmaceutical Sciences, College of Clinical Pharmacy, King Faisal University, Al-Ahsa 31982, Saudi ArabiaDepartment of Biotechnology and Food Technology, Durban University of Technology, Durban 4001, South AfricaDepartment of Biomedical Sciences, College of Clinical Pharmacy, King Faisal University, Al-Ahsa 31982, Saudi ArabiaDepartment of Public Health Medicine, Howard College Campus, University of KwaZulu-Natal, Durban 4001, South AfricaDepartment of Biomedical Sciences, College of Veterinary Medicine, King Faisal University, Al-Ahsa 31982, Saudi ArabiaDepartment of Studies in Chemistry, Shivagangotri, Davangere University, Davangere, Karnataka 577007, IndiaDepartment of Pharmacology, Faculty of Medicine, Minia University, El-Minia 61511, EgyptThe cyclooxygenase-2 (COX-2) enzyme is an important target for drug discovery and development of novel anti-inflammatory agents. Selective COX-2 inhibitors have the advantage of reduced side-effects, which result from COX-1 inhibition that is usually observed with nonselective COX inhibitors. In this study, the design and synthesis of a new series of 7-methoxy indolizines as bioisostere indomethacin analogues (<b>5a</b>–<b>e</b>) were carried out and evaluated for COX-2 enzyme inhibition. All the compounds showed activity in micromolar ranges, and the compound diethyl 3-(4-cyanobenzoyl)-7-methoxyindolizine-1,2-dicarboxylate (<b>5a</b>) emerged as a promising COX-2 inhibitor with an IC<sub>50</sub> of 5.84 µM, as compared to indomethacin (IC<sub>50</sub> = 6.84 µM). The molecular modeling study of indolizines indicated that hydrophobic interactions were the major contribution to COX-2 inhibition. The title compound diethyl 3-(4-bromobenzoyl)-7-methoxyindolizine-1,2-dicarboxylate (<b>5c</b>) was subjected for single-crystal X-ray studies, Hirshfeld surface analysis, and energy framework calculations. The X-ray diffraction analysis showed that the molecule (<b>5c</b>) crystallizes in the monoclinic crystal system with space group <i>P</i> 2<sub>1</sub>/n with <i>a</i> = 12.0497(6)Å, <i>b</i> = 17.8324(10)Å, <i>c</i> = 19.6052(11)Å, <i>α</i> = 90.000°, <i>β</i> = 100.372(1)°, <i>γ</i> = 90.000°, and V = 4143.8(4)Å<sup>3</sup>. In addition, with the help of <i>Crystal Explorer</i> software program using the B3LYP/6-31G(d, p) basis set, the theoretical calculation of the interaction and graphical representation of energy value was measured in the form of the energy framework in terms of coulombic, dispersion, and total energy.https://www.mdpi.com/1420-3049/26/12/3550indolizine derivativesmolecular modelingCOX-2 inhibitioncrystal structureHirshfeld surface analysisenergy framework |